News
Approval was based on results from the Phase III inMIND trial, which demonstrated a statistically significant and clinically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback